Dashboard
Analysis
Charting
Screener
Resources
Settings
TSX-ATD
Apr '15
Oct '16
Apr '18
Oct '19
Apr '21
Oct '22
Apr '24
Oct '25
Trailing Valuation
Stock Price
52.2
52.5
56.9
54.5
49.9
Total Shares Outstanding
931.9
948.1
948
957.1
963.9
981.3
Market Cap
48,614.2
49,448.3
49,752.7
54,394.6
52,466.7
48,601.2
Total Enterprise Value (TEV)
63,488
61,978.3
57,241.3
Dividend Yield
0.5%
—
0.4%
Buyback Yield
1.8%
1.1%
1.7%
3.4%
Debt Paydown Yield
-2.2%
1%
-1.1%
0.3%
Shareholder Yield
-0.4%
2.1%
0.6%
3.7%
P/S
1.4
1.3
1.5
1.6
P/Gross Profit
7.2
7.4
7.9
8.7
8.9
7.7
P/E
32.4
45.8
33.4
50.7
32
34.9
Earnings Yield
3.1%
2.2%
3%
2%
2.9%
P/OCF
19.7
21.5
22.6
23.4
P/FCF
30.6
35.5
32.6
52.1
FCF Yield
3.3%
2.8%
1.9%
P/B
3.2
3.3
3.9
EV/Sales
1.8
1.7
EV/Gross Profit
9.4
9.3
9.1
EV/EBITDA
37.8
16.3
34.5
17.7
20.6
EV/EBIT
29.4
23.3
29.7
EV/OCF
25.7
27.6
EV/FCF
39.9
61.4
Dividends
DPS
0.3
0.2
Payout Ratio
17.5%
16.4%
12.4%
6.7%
Margins
Gross Profit Margin
19.1%
18%
17.7%
16.7%
18.3%
17.4%
Operating Margin
6.1%
4.4%
6%
4.2%
7%
5.3%
EBITDA Margin
9.2%
8.5%
9.3%
7.7%
Net Profit Margin
4.3%
5.2%
3.9%
Effective Tax Rate
23%
20.1%
23.3%
22.8%
20.6%
Pre-Tax Profit Margin
5.6%
5.5%
3.5%
4.9%
Free Cash Flow Margin
4.5%
5%
2.6%
OCF / Sales
6.5%
7.2%
5.7%
OCF / Net Income
161.5%
153.6%
140.5%
147.5%
FCF / OCF
64.4%
60.6%
69.3%
44.9%
FCF / Net Income
104%
93.1%
97.4%
66.3%
FCF / EBITDA
49.3%
46%
54.2%
33.5%
Capital Efficiency
Return on Invested Capital
11.4%
9.8%
15.7%
Return on Assets
8.2%
6.8%
10.5%
Return on Equity
5.4%
4.1%
22.4%
Return on Total Capital
18.9%
17%
30.3%
Return on Capital Employed
13.4%
10.7%
16.1%
Return on Tangible Assets
7.9%
13%
Receivables Turnover
23.6
26.1
30.3
Days Sales Outstanding
15.5
14
12.1
Payables Turnover
9.7
10.6
13.3
Days Payables Outstanding
37.5
34.3
27.4
Inventory Turnover
23.7
27.9
Days Inventory Outstanding
15.4
13.1
13.2
Cash Conversion Cycle
-6.6
-7.2
-2.1
Asset Turnover
1.9
2.5
Fixed Asset Turnover
3.5
4.8
Operating Cycle
30.9
27.1
25.3
CapEx to OCF
0.4
0.6
CapEx to Revenue
0
CapEx to Depreciation
0.8
1
Financial Health
Total Debt
16,862.7
14,646.5
9,474.3
Net Debt
14,738.1
12,383.5
8,640.1
Current Ratio
0.9
1.1
Quick Ratio
0.7
Cash Ratio
Debt Ratio
Assets to Equity
2.3
Cash Flow to Debt Ratio
0.1
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-17,442.6
-15,827.3
-10,824.3
Goodwill / Assets
Debt / Equity
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
4.6
7.6
3.1
EBIT / Interest Expense
6.4
4.4
6.7
10.5
8.6
EBITDA / Interest Expense
9.5
13.9
12.4
(EBITDA - Capex) / Interest Expense
6.9
7.3
Per Share
Revenue per Share
37.3
39.2
37.4
38.7
32.9
36.5
Basic EPS
1.2
Diluted EPS
Book Value per Share
15.8
12.6
Tangible Book Value per Share
3.6
4.5
5.2
Cash per Share
2.2
2.4
Operating Cash Flow per Share
2.6
2.1
Free Cash Flow per Share
CapEx per Share
Weighted Avg. Shares Outstanding
944.1
947.8
952.4
960.9
972.5
992.1
Weighted Avg. Shares Outstanding Diluted
944.6
953.1
962.3
974.1
994
Common Size
SG&A to Revenue
9.9%
10.4%
9.7%
9.1%
